Preclinical studies in rodents, as well as the efficacy study in client-owned dogs with spontaneous bladder cancer, show that vaccination against extracellular vimentin is safe, emphasizing the specificity of extracellular vimentin for tumor angiogenesis. This evidence concerns the gene VIM and urinary bladder carcinoma.